Don't know what you got till it's gone: microglial depletion and neurodegeneration

David Graykowski1, Eiron Cudaback1

  • 1Department of Health Sciences, DePaul University, Chicago, IL, USA.

Insights

Microglia, the brain's immune cells, are crucial for neural health and neurodegenerative disease research. New depletion strategies, like CSF1R inhibitors, offer advanced tools for studying their roles in conditions such as Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the primary immune cells in the central nervous system, originating from embryonic myeloid precursors.
  • They play vital roles in neural development, network maintenance, neuroregeneration, and immune surveillance throughout life.

Purpose of the Study:

  • To review the efficacy and utility of various microglial depletion strategies in neuroscience research.
  • To explore the relationship between microglia and neurodegenerative diseases, particularly Alzheimer's disease.
  • To discuss the therapeutic potential of microglial depletion and repopulation.

Main Methods:

  • Discussion of genetic models for microglial manipulation.
  • Evaluation of pharmacologic approaches, including CSF1R (colony-stimulating factor 1 receptor) inhibitors.
  • Analysis of in vitro and in vivo microglial depletion techniques.

Main Results:

  • CSF1R inhibitor models demonstrate high efficacy in selective and near-complete microglial depletion.
  • Advances in depletion strategies significantly enhance the understanding of microglial functions in health and disease.
  • Insights into the complex interplay between microglia and neurodegeneration are highlighted.

Conclusions:

  • Selective microglial depletion is a powerful tool for neuroscience research, particularly for studying neurodegenerative disorders.
  • Understanding microglial roles is critical for developing therapeutic strategies for Alzheimer's disease and other neurological conditions.
  • Repurposing microglial depletion and repopulation techniques holds promise for future therapeutic interventions.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...